Market revenue in 2023 | USD 26.7 million |
Market revenue in 2030 | USD 39.9 million |
Growth rate | 5.9% (CAGR from 2023 to 2030) |
Largest segment | Percutaneous thrombectomy devices |
Fastest growing segment | Neurovascular Embolectomy Devices |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Neurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Percutaneous Thrombectomy Devices, Catheter-directed thrombolysis (CDT) devices, Inferior vena cava filters (IVCF) |
Key market players worldwide | Medtronic PLC, Boston Scientific Corp, Teleflex Inc, Edwards Lifesciences Corp, LeMaitre Vascular Inc, Cook Medical, DePuy Synthes, iVascular, Vascular Solutions |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clot management devices market will help companies and investors design strategic landscapes.
Percutaneous thrombectomy devices was the largest segment with a revenue share of 36.33% in 2023. Horizon Databook has segmented the Brazil clot management devices market based on neurovascular embolectomy devices, embolectomy balloon catheters, percutaneous thrombectomy devices, catheter-directed thrombolysis (cdt) devices, inferior vena cava filters (ivcf) covering the revenue growth of each sub-segment from 2018 to 2030.
Brazil accounted for 34.23% of Latin America’s clot management devices market in 2022. Improving healthcare expenditure in the country is expected to augment market growth over the forecast period. For instance, according to OECD, Brazil spent 9.6% of its GDP on healthcare in 2019, while constituting the largest healthcare market in Latin America.
Moreover, the growing clinical evidence to use mechanical thrombectomy as a method to treat stroke aids market growth. For instance, in June 2020, Massachusetts Medical Society conducted a randomized trial in Brazil, which revealed that mechanical thrombectomy in conjunction with standard treatment improves stroke patient outcomes.
According to John Wiley & Sons, Inc., cancer and fatal injuries are the primary causes of developing VTE. In addition, VTE-related deaths accounted for 1.6% of all deaths in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil clot management devices market , including forecasts for subscribers. This country databook contains high-level insights into Brazil clot management devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account